Gwenn Hansen
Known title: Chief Scientific OfficerCIK: 0001817160
Associated companies
Transaction History
| NRIX | ▲ Buy | Option Exercise | 1,452 | $3K | 9/1/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,452 | $37K | 9/1/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 4,356 | $8K | 8/5/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 4,356 | $109K | 8/5/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,500 | $36K | 8/4/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,611 | $64K | 8/4/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 7/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 7/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,572 | $0 | 7/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,847 | $90K | 7/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,394 | $108K | 6/25/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 4/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 4/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,214 | $53K | 4/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 4/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 31,333 | $26K | 2/3/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 1/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,859 | $0 | 1/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 4,797 | $80K | 1/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 98 | $2K | 1/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 1/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 1/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 10/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 10/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 10/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 10/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 4,087 | $52K | 10/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 7/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 7/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 7/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 7/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 4,308 | $52K | 7/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,377 | $39K | 4/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,206 | $0 | 4/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 4/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 4/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 1/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 1/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 1/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 333 | $7K | 1/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,357 | $66K | 1/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 10/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 10/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 10/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,437 | $84K | 10/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 7/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 7/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 7/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,408 | $70K | 7/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 4/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,206 | $0 | 4/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,007 | $24K | 4/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,334 | $19K | 1/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 1/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 1/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,633 | $8K | 10/31/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 10/30/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 10/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,884 | $18K | 7/31/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 7/30/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 7/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,136 | $11K | 5/1/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,206 | $0 | 4/30/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 1/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,412 | $17K | 1/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,165 | $15K | 10/31/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 10/30/2022 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,186 | $19K | 8/1/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,207 | $0 | 7/30/2022 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,098 | $13K | 5/2/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,206 | $0 | 4/30/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 400 | $3K | 1/3/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,428 | $14K | 1/3/2022 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,828 | $53K | 1/3/2022 | View on chart |
| NRIX | ▼ Sell | Open Market | 400 | $12K | 12/1/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 400 | $3K | 12/1/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 400 | $3K | 11/1/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 400 | $13K | 11/1/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 400 | $3K | 10/27/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 400 | $14K | 10/27/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 400 | $12K | 10/1/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 400 | $3K | 10/1/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,600 | $12K | 9/7/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,600 | $56K | 9/7/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 400 | $3K | 9/1/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 400 | $13K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Nurix Advances Bexobrutideg Studies and Secures $10M Gilead Extension
Nurix has enrolled its first patient in a Phase 1b/2 study of Bexobrutideg for chronic lymphocytic leukemia, and a second enrollment began for a Bexobrutideg plus Venetoclax combination under a Roche partnership. The company also received a second research term extension for its oncology program with Gilead Sciences and secured $10 million from Gilead as part of the extended drug‑discovery collaboration. These developments show ongoing progress in Nurix’s pipeline and continued partnership support.
Nurix Advances Bexobrutideg Studies and Secures $10M Gilead Extension. Nurix has enrolled its first patient in a Phase 1b/2 study of Bexobrutideg for chronic lymphocytic leukemia, and a second enrollment began for a Bexobrutideg plus Venetoclax combination under a Roche partnership. The company also received a second research term extension for its oncology program with Gilead Sciences and secured $10 million from Gilead as part of the extended drug‑discovery collaboration. These developments show ongoing progress in Nurix’s pipeline and continued partnership support.